The Current Ratio as of November 2024 (TTM) for Kamada Ltd. (KMDA) is 4.84

According to Kamada Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 4.84. This represents a change of 16.60% compared to the average of 4.15 of the last 4 quarters.

Kamada Ltd. (KMDA) Historical Current Ratio (quarterly & annually)

How has KMDA Current Ratio performed in the past?

The mean historical Current Ratio of Kamada Ltd. over the last ten years is 3.67. The current 4.84 Current Ratio has changed 13.08% with respect to the historical average. Over the past ten years (40 quarters), KMDA's Current Ratio was at its highest in in the March 2021 quarter at 7.97. The Current Ratio was at its lowest in in the December 2022 quarter at 1.84.

Kamada Ltd. (KMDA) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Kamada Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Kamada Ltd. (KMDA) Average Current Ratio

How has KMDA Current Ratio performed in the past?

The current Current Ratio of Kamada Ltd. (KMDA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Kamada Ltd. (KMDA) Current Ratio vs. Peers

How is KMDA’s Current Ratio compared to its peers?

Kamada Ltd.’s Current Ratio is greater than Lifecore Biomedical, Inc. (1.83), greater than Shuttle Pharmaceuticals Holdings, Inc. (0.22), greater than Cumberland Pharmaceuticals Inc. (1.13), greater than Ironwood Pharmaceuticals, Inc. (3.62), greater than Mallinckrodt plc (2.74), greater than Organogenesis Holdings Inc. (3.09), greater than Lucy Scientific Discovery Inc. (0.38), greater than Alimera Sciences, Inc. (2.79), greater than Agile Therapeutics, Inc. (0.55), less than Guardion Health Sciences, Inc. (16.67), greater than Akanda Corp. (1.41), greater than Evoke Pharma, Inc. (1.44), greater than Collegium Pharmaceutical, Inc. (0.97), greater than Dr. Reddy's Laboratories Limited (1.92), greater than Pacira BioSciences, Inc. (2.25), greater than Perrigo Company plc (2.56), greater than Eagle Pharmaceuticals, Inc. (1.70), greater than ANI Pharmaceuticals, Inc. (2.74), greater than Phibro Animal Health Corporation (3.23), greater than Deciphera Pharmaceuticals, Inc. (4.19), greater than Prestige Consumer Healthcare Inc. (3.56),

Build a custom stock screener for Kamada Ltd. (KMDA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kamada Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Kamada Ltd. (KMDA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Kamada Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.